Mitochondrial DNA copy number is associated with cognitive impairment: Developing topics. (7th December 2020)

• Record Type: Journal Article
• Authors: Andrews, Shea J; Goate, Alison M
• Is Part Of: Alzheimer's & dementia. Volume 16(2020)Supplement 5
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-12-07
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.047543
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: Increasing evidence has implicated mitochondrial dysfunction in the pathogenesis of Alzheimer's Disease. Mitochondria contain their own DNA outside of the nuclear genome, with every cell having between 100‐10, 000 copies of mtDNA. Mitochondrial DNA copy number (mtDNAcn) has been used as a surrogate measure of mitochondrial function, with reduced mtDNAcn associated with age‐related diseases. The aim of this study was to evaluate the association of mtDNAcn with cognitive impairment. Methods: We evaluated the association of mtDNAcn with the extended Clinical Dementia Rating (CDR) scale in the Mount Sinai Brain Bank (MSBB) and with mini mental state exam (MMSE) in the Religious Orders Studies and the Memory Aging Project (ROSMAP). Relative mtDNAcn was estimated as the ratio of mitochondrial genomes to nuclear genomes in 1025 non‐Hispanic white subjects (MSBB = 277; ROSMAP = 748) using whole‐genome sequencing data generated from DNA isolated from post‐mortem brain tissue (MSBB: prefrontal cortex; ROSMAP: dorsolateral prefrontal cortex [DLPFC], posterior cingulate cortex [PCC], or cerebellum). Linear regression adjusting for age of death, sex, APOE, study, mitochondrial haplogroup and source tissue were used to evaluate the association of mtDNAcn with cognitive impairment. Results: In the MSBB, a one standard deviation decrease (1 s.d. 343) in mtDNAcn was associated with a higher CDR score (b(se) = 0.71 (0.10), p = 3.41e‐12, Fig. 1). Similarly, in ROSMAP a one standard deviation decrease (1 s.d. 1063) in mtDNAcn was associated with a lower MMSE score (b(se) = ‐4.02 (0.75), p = 1.07e‐7, Fig. 2). Conclusion: Mitochondrial dysfunction as measured by mtDNAcn is associated with worse cognitive performance, suggesting that mitochondrial function plays a role in the pathogenesis of Alzheimer's Disease. However, further research is needed to determine if mitochondrial dysfunction causes, mediates, or is a by‐product of AD pathogenesis, in particular whether neuronal loss is an unobserved confounder that could be driving the observed associations.